Prime Capital Investment Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Prime Capital Investment Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-343	Closed	-$6K	–	444
2022 Q1	$6K	Hold	343	–	–	﹤0.01%	342
2021 Q4	$6K	Hold	343	–	–	﹤0.01%	343
2021 Q3	$9K	Hold	343	–	–	﹤0.01%	297
2021 Q2	$11K	Buy	+343	New	+$11.1K	﹤0.01%	376

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Prime Capital Investment Advisors's ZSAN Position: Q2 2022 in Review

Prime Capital Investment Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 343 shares — an estimated $6K sold.

Prime Capital Investment Advisors first reported a position in ZSAN in Q2 2021 and held it in 4 quarters. The position peaked at $11K in Q2 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Prime Capital Investment Advisors reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Prime Capital Investment Advisors sold 343 Zosano Pharma Corporation shares in Q2 2022, an estimated $6K.
Prime Capital Investment Advisors first reported a position in Zosano Pharma Corporation in Q2 2021 and held it in 4 quarters.
Prime Capital Investment Advisors's Zosano Pharma Corporation position peaked at $11K in Q2 2021.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.